Skip to main content

Horizons Marijuana Life Sciences ETF(HMMJ-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Horizons Marijuana Life Sciences ETF down on Thursday (HMMJ)

Automated Summaries - The Globe and Mail - Thu Mar 28, 4:01PM CDT

In trading today, Horizons Marijuana Life Sciences ETF shares closed at $10.99 after opening the day at $11.20. It traded at a low of $10.97 to a high of $11.34.

The price decreased -1.87% from the previous day's close of $11.20.

During the day across North America, the TSX Composite closed 0.89% at 22107.08, the S&P 500 closed 0.86% at 5248.49, the Dow Jones Industrial Average closed 1.22% at 39760.08 and the Nasdaq Composite closed 0.51% at 16399.52.

Horizons Marijuana Life Sciences ETF traded under HMMJ on the Toronto Stock Exchange (TSX).

A total of 12,127 shares was traded during the session, with total trades of 72, with an average volume of 28,829 in the last five days.

Trading across the entire TSX saw 3,239 price advancers against 2,014 declines and 115 unchanged.

During the prior 52 weeks, HMMJ.TO has traded as high as $11.61 (September 12,2023) and low as $8.07 (October 27,2023). Moreover, in the last 12 months, Horizons Marijuana Life Sciences ETF's shares have advanced 5.67%, while they have boosted 18.30% since the start of 2024.

Following today's trading, Horizons Marijuana Life Sciences ETF has a market capitalization of $93.14 million on a float of 8,316 shares outstanding. Its annual EPS is $None.

Horizons Marijuana Life Sciences ETF is a None company headquartered in, None.

The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The Index is designed to provide exposure to the performance of a basket of North American publicly listed life sciences companies with significant business activities in the marijuana industry..

Currently, Horizons Marijuana Life Sciences ETF's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe